AURORA CANNABIS (21P.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
At close: 04:43PM CEST
Loading interactive chart...
- Zacks
ACB Stock Likely to Gain From Genome BC-Funded Aroma Research Project
Aurora Cannabis' new collaboration on the Genome BC-Funded Project addresses distinct cannabis aromas.
- Baystreet
Stocks in play: Aurora Cannabis Inc.
Announced a research grant provided to the University of British Columbia (UBC) by Genome British Columbia ...
- PR Newswire
Aurora Cannabis Announces Collaboration on Genome BC-Funded Project Addressing Distinct Cannabis Aromas
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) –—the Canadian based leading global medical cannabis company, today announced a research grant provided to the University of British Columbia (UBC) by Genome British Columbia (Genome BC), a not-for-profit organization supporting world-class genomics research and innovation in British Columbia. The project, Genomics-enabled Aroma Breeding in Cannabis, will directly support Aurora's genetics work the project, is led by Drs. Jose Celedon, Principal Scie
© 2024 Yahoo. All rights reserved.